Average Co-Inventor Count = 6.68
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (10 from 413 patents)
2. Centocor Ortho Biotech Inc. (3 from 31 patents)
3. Other (1 from 832,966 patents)
4. Medimmune Limited (1 from 541 patents)
5. Fundacio Privada Institut D'investigacio Oncologic (1 from 1 patent)
6. Fundacio Privada Institucio Catalana De Recerca I (1 from 1 patent)
7. Boehringer Ingelheim Io Canada Inc. (1 from 1 patent)
8. Fundacio Privada Institut D'investigacio Oncologica De Vall Hebron (7 patents)
9. Fundacio Privada Institucio Catalana De Recerca I Estudis Avancats (2 patents)
16 patents:
1. 12473365 - FLT3 AGONIST ANTIBODIES AND USES THEREOF
2. 11732050 - Neutralizing human anti-CD27 antibodies
3. 11421037 - Nucleic acids encoding anti-CD154 antibodies
4. 11390670 - Antibodies against LIF and uses thereof
5. 10941197 - Method of treating osteoarthritis with human oncostatin M antibodies
6. 10689453 - Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies
7. 10669343 - Anti-CD154 antibodies and methods of using them
8. 10544229 - Agonistic antibodies specifically binding CD40 and methods of use
9. 10301392 - Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies
10. 9683046 - Nucleic acid molecules encoding anti-CD27 antibodies
11. 9163083 - Human oncostatin M antibodies
12. 9102737 - Human anti-CD27 antibodies, methods and uses
13. 8728985 - Display of disulfide linked dimeric proteins in filamentous phage
14. 8580714 - Methods of affinity maturing antibodies
15. 8399630 - Engineered anti-IL-13 antibodies, compositions, methods and uses